Wiley BROS. Aintree Capital LLC lowered its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.8% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 11,352 shares of the real estate investment trust’s stock after selling 1,374 shares during the quarter. Wiley BROS. Aintree Capital LLC’s holdings in National Health Investors were worth $821,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of NHI. Norges Bank purchased a new stake in shares of National Health Investors during the 4th quarter worth about $40,753,000. BlackRock Inc. boosted its holdings in National Health Investors by 6.3% in the 4th quarter. BlackRock Inc. now owns 4,475,657 shares of the real estate investment trust’s stock worth $309,582,000 after acquiring an additional 266,783 shares during the period. Waterfront Capital Partners LLC purchased a new position in National Health Investors in the 4th quarter worth approximately $13,864,000. JPMorgan Chase & Co. boosted its holdings in National Health Investors by 109.5% in the 4th quarter. JPMorgan Chase & Co. now owns 303,358 shares of the real estate investment trust’s stock worth $20,983,000 after acquiring an additional 158,570 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in National Health Investors by 7.0% in the 4th quarter. Bank of New York Mellon Corp now owns 1,210,587 shares of the real estate investment trust’s stock worth $83,737,000 after acquiring an additional 78,743 shares during the period. Institutional investors and hedge funds own 65.72% of the company’s stock.
A number of research firms have weighed in on NHI. KeyCorp upgraded National Health Investors from an “underweight” rating to a “sector weight” rating in a report on Monday, December 14th. Truist Securities upped their target price on National Health Investors from $69.00 to $74.00 in a research report on Tuesday, March 23rd. Zacks Investment Research lowered National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, February 24th. Truist upped their target price on National Health Investors from $69.00 to $74.00 in a research report on Tuesday, March 23rd. Finally, Mizuho lowered National Health Investors from a “neutral” rating to an “underperform” rating and cut their target price for the company from $56.00 to $55.00 in a research report on Wednesday, January 13th. Three equities research analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. National Health Investors has a consensus rating of “Hold” and a consensus price target of $66.40.
National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Sunday, February 21st. The real estate investment trust reported $0.82 EPS for the quarter, missing the Zacks’ consensus estimate of $1.01 by ($0.19). The company had revenue of $81.24 million for the quarter, compared to the consensus estimate of $84.22 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. National Health Investors’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.41 earnings per share. As a group, research analysts anticipate that National Health Investors, Inc. will post 5.59 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 7th. Investors of record on Wednesday, March 31st will be paid a dividend of $1.102 per share. The ex-dividend date is Tuesday, March 30th. This represents a $4.41 dividend on an annualized basis and a yield of 5.93%. National Health Investors’s payout ratio is currently 80.18%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Further Reading: What is the role of the G-20?
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.